Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 PF-03446962 monotherapy in cancer
jRCT2080221460Phase 1Completed
- Start
- May 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 1, single-arm trial of ascrinvacumab in cancer. Started May 2011; status: completed.
02
Drugs
ascrinvacumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080221460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221460.